Navigation Links
Albright Technologies, the Leader in Medical Silicone Molding, Appoints New President
Date:3/28/2013

Leominster, MA (PRWEB) March 28, 2013

Albright Technologies today announced that David Comeau has stepped down as the company’s President, effective January 1, 2013. Comeau will continue to contribute on the technical side as part owner while working on a start-up project. Bob Waitt, formerly the VP of Business Development, will assume the role of President and CEO.

Like many small companies, Albright was started in a garage with only a few employees. Over the last 18 years Albright has grown into a successful company with 15 employees, a clean room, machine shop and molding room. The company began with the original focus of medical plastic prototyping. However, the world of medical device manufacturing continued to evolve with medical researchers looking for products to better suit the human body. So in 2005, Albright made a strategic decision to transition from plastic to silicone, a more bio-inert material.

Bob Waitt has been with the company for 12 years and has served as the VP of Business Development since 2008. He started with the company in 2000, then received a Bachelor of Science in Electrical Engineering from Boston University in 2006 and has since been concentrating on helping Albright expand, evolve and become a leader in the silicone molding industry.

“Bob Waitt has been my partner for the last 5 years and has had an integral role in growing the company into what it is today; I am happy now to be turning the company over to him,” said Comeau. “Bob started with the company in 2000, and has had many positions over his years at Albright allowing him to learn all aspects of the company. I have great confidence that he will continue to move Albright forward and keep it growing to its full potential.”

Everyone at Albright Technologies expresses their sincere appreciation to Comeau for his service and dedication.

About Albright Technologies:

Founded in 1995 and headquartered in Leominster, MA, USA, Albright Technologies specializes in manufacturing prototype and low volume production silicone components for Medical, Pharmaceutical, Military and Consumer Goods applications. Albright Technologies has extensive silicone molding experience and can provide silicone material selection, prototyping and design for manufacturability and scalable molding methods. Albright Technologies has created a free silicone design manual that has been downloaded over 10,000 times. For more information about Albright Technologies, contact Bob Waitt at 978-466-5870 or info(at)albright1(dot)com. To receive an online quote, request samples or download the newly revised Silicone Molding Design Manual, visit http://www.albright1.com.

Albright Technologies
25 Litchfield Street
Leominster, MA 01453
P 978-466-5870
F 978-466-5901

Read the full story at http://www.prweb.com/releases/2013/3/prweb10560033.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Research and Markets - Drug Delivery in Cancer - Technologies, Markets and Companies - 2013 Report
2. Ultimate Aquatics, announces the acquisition of SUP Products, the industry leader in U.S. Made Private Label Hybrid Molded Composite (HMC) Stand Up Paddle Boards (SUP) & Accessories.
3. Michigan hospitals national leaders in preventing common and costly urinary tract infections
4. Registered Nurses Association gives awards to 2 St. Michaels nursing leaders
5. Geiger Gibson Program recognizes 8 emerging leaders at annual symposium
6. Townsend Security Releases Short, Easy to Understand Data Privacy Videos for Business Leaders
7. AIBS names emerging public policy leaders
8. Best Injury Lawyers? Time Magazine Includes McDonaldWorley.com Among Nations Legal Leaders
9. eHealth Thought Leadership Forum Accepting New Council Members
10. World Leader In Manufacturing Of Cleaning Solutions; Midbrook Medical, Announces The Launch Of UV Flash, 60 Second Infection Prevention Station Designed To Combat HAI's
11. Sequestration is not a smart strategy for reducing the deficit, say small business leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
(Date:6/20/2017)... ... , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. Kejriwal ... leading-edge care, whether or not they have a referral. Dr. Kejriwal offers state-of-the-art ... laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. This ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... (AHN) Jefferson Hospital is providing physicians with advanced capabilities for diagnosing and treating ... than traditional MRIs, enabling doctors to get a more accurate look inside the ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: